• 日本語
  • Contact Us
  • Site Map

Clinical Trial Business

tel

Support for Drug Discovery Studies

To support for effective and speedy progress of drug discovery stage in drug development, we provide various tools for exploring and identifying therapeutic targets, and we also have technologies for highly sensitive analyses of candidates in early stage screening.

We contract non-GLP bioanalysis services for drug development (development of analytical methods with higher sensitivity, and analyses for exploratory PK studies, etc.) by LC/MS/MS and ligand binding assay (LBA).

  • Investigation and development of analytical methods for new candidates and biomarkers in biological matrices
  • Investigation and development of ultrasensitive analytical methods (in pg/mL or fg/mL)
  • Others (collaborative researches)

Equipment

LC-MS/MS

  • For sensitive quantitative analyses:
    • QTRAP 6500, QTRAP 5500
  • For ultrasensitive quantitative analyses:
    • Q EXACTIVE FOCUS
    • QTRAP 5500 with hybrid ionization system
  • For qualitative analyses:
    • Triple TOF 5600 with nano flow LCsystem

LBA

  • MESO QuickPlex SQ 120
  • Gyrolab xP

back to top

Contact